Clinical Trial Update: Evaluate Safety, Whole-Body Distribution and Radiation Dosimetry in Metastatic Castration Resistant Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update from Sichuan University reports safety, whole-body distribution, and radiation dosimetry data in patients with metastatic castra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: Sichuan University | Conditions: Metastatic Prostate Cancer | EARLY_Phase 1 | Status: COMPLETED